Cormorant Asset Management, LP Q1 2021 Filing
Filed May 17, 2021
Portfolio Value
$4.5B
Holdings
119
Report Date
Q1 2021
Filing Type
13F-HR
All Holdings (119 positions)
| Stock | Value |
|---|---|
IWMISHARES TR | $441.9M |
SPYSPDR S&P 500 ETF TR | $396.3M |
AVIRATEA PHARMACEUTICALS INC | $395.9M |
—TURNING POINT THERAPEUTICS I | $260.1M |
DSGNDESIGN THERAPEUTICS INC | $146.4M |
XBISPDR SER TR | $135.7M |
BBIOBRIDGEBIO PHARMA INC | $133.6M |
—FORMA THERAPEUTICS HLDGS INC | $132.3M |
RVMDREVOLUTION MEDICINES INC | $115.8M |
BCABBIOATLA INC | $109.9M |
OLMAOLEMA PHARMACEUTICALS INC | $105.1M |
CCCCC4 THERAPEUTICS INC | $92.1M |
APLSAPELLIS PHARMACEUTICALS INC | $80.1M |
OMEROMEROS CORP | $76.5M |
EWTXEDGEWISE THERAPEUTICS INC | $74.3M |
ALXOALX ONCOLOGY HLDGS INC | $65.0M |
—ZYMEWORKS INC | $63.2M |
RCKTROCKET PHARMACEUTICALS INC | $60.7M |
STOKSTOKE THERAPEUTICS INC | $55.8M |
TARSTARSUS PHARMACEUTICALS INC | $55.3M |
RNAAVIDITY BIOSCIENCES INC | $53.8M |
ACRSACLARIS THERAPEUTICS INC | $50.4M |
MRTXEURMIRATI THERAPEUTICS INC | $47.1M |
NVV1NOVAVAX INC | $45.3M |
CCXIEURCHEMOCENTRYX INC | $43.6M |
AXNX*AXONICS MODULATION TECHNOLOG | $41.5M |
DMTKQDERMTECH INC | $40.6M |
RETAEURREATA PHARMACEUTICALS INC | $39.9M |
1K0IGM BIOSCIENCES INC | $38.0M |
XLRNACCELERON PHARMA INC | $37.3M |
YMABUSDY-MABS THERAPEUTICS INC | $37.2M |
—LONGBOARD PHARMACEUTICALS IN | $37.2M |
—PROMETHEUS BIOSCIENCES INC | $36.6M |
PRAXPRAXIS PRECISION MEDICINES I | $35.2M |
VERUEURVERU INC | $32.3M |
ALGSALIGOS THERAPEUTICS INC | $28.8M |
MASS908 DEVICES INC | $25.9M |
NTLAINTELLIA THERAPEUTICS INC | $24.1M |
PLRXPLIANT THERAPEUTICS INC | $24.0M |
2L9BLUEPRINT MEDICINES CORP | $24.0M |
—APTOSE BIOSCIENCES INC | $23.9M |
PHVSPHARVARIS N V | $23.8M |
TWSTTWIST BIOSCIENCE CORP | $22.9M |
SRNESORRENTO THERAPEUTICS INC | $22.7M |
MORFMORPHIC HLDG INC | $22.1M |
SPRYSILVERBACK THERAPEUTICS INC | $21.8M |
AKROAKERO THERAPEUTICS INC | $21.5M |
CABACABALETTA BIO INC | $21.1M |
AGENEURAGENUS INC | $21.1M |
—MYOVANT SCIENCES LTD | $20.6M |
ZLABZAI LAB LTD | $20.0M |
—TCR2 THERAPEUTICS INC | $19.9M |
KALVKALVISTA PHARMACEUTICALS INC | $19.3M |
0KB2HUMANIGEN INC | $19.1M |
CNTBCONNECT BIOPHARMA HLDGS LTD | $18.5M |
BDQMALBIREO PHARMA INC | $17.6M |
INSPINSPIRE MED SYS INC | $17.6M |
ELDNELEDON PHARMACEUTICALS INC | $15.1M |
RPTXREPARE THERAPEUTICS INC | $14.2M |
ANABANAPTYSBIO INC | $14.0M |
BEAMBEAM THERAPEUTICS INC | $13.7M |
—BIOHAVEN PHARMACTL HLDG CO L | $13.7M |
FHTXFOGHORN THERAPEUTICS INC | $13.2M |
GLTOUSDGALECTO INC | $13.1M |
ASNDASCENDIS PHARMA A/S | $12.9M |
—HARPOON THERAPEUTICS INC | $11.9M |
AXSMAXSOME THERAPEUTICS INC | $11.3M |
TBPHTHERAVANCE BIOPHARMA INC | $11.2M |
0HJQAVEO PHARMACEUTICALS INC | $11.0M |
BNTXBIONTECH SE | $10.9M |
5E7ITEOS THERAPEUTICS INC | $10.3M |
IM8NINSMED INC | $10.2M |
SWTXSPRINGWORKS THERAPEUTICS INC | $9.2M |
—HEALTH SCIENCES ACQ CORP 2 | $9.0M |
DCPHEURDECIPHERA PHARMACEUTICALS IN | $9.0M |
—BCTG ACQUISITION CORP | $8.9M |
FDMT4D MOLECULAR THERAPEUTICS IN | $8.7M |
QUREUNIQURE NV | $8.4M |
ARGXARGENX SE | $8.3M |
GOSSGOSSAMER BIO INC | $7.8M |
VRDNVIRIDIAN THERAPEUTICS INC | $7.7M |
MRUSMERUS N V | $7.3M |
—MAGENTA THERAPEUTICS INC | $7.1M |
—AKOUOS INC | $6.9M |
—GENETRON HLDGS LTD | $6.4M |
—GEMINI THERAPEUTICS INC | $6.4M |
CGEMCULLINAN ONCOLOGY INC | $6.3M |
—QUOTIENT LTD | $5.5M |
TARAPROTARA THERAPEUTICS INC | $5.5M |
IMVTIMMUNOVANT INC | $5.4M |
—BCLS ACQUISITION CORP | $5.3M |
—THERAPEUTICS ACQUISITION COR | $5.3M |
SRPTSAREPTA THERAPEUTICS INC | $5.2M |
—5 01 ACQUISITION CORP | $5.0M |
—VESPER HEALTHCARE ACQSTN COR | $4.6M |
BCELATRECA INC | $4.5M |
MLTXHELIX ACQUISITION CORP | $4.4M |
REPLREPLIMUNE GROUP INC | $3.8M |
TILINSTIL BIO INC | $3.8M |
DTILPRECISION BIOSCIENCES INC | $3.6M |
Page 1 of 2Next